Abstract
The article is dedicated to the problem of patients management optimization, who underwent operations for different forms of ischemic heart disease in real terms of practical healthcare. Low adherence to regular medical check-up and to some important variants of medication (inadequate prescription of statins, ACE-inhibitors, beta-blockers) were revealed. A new method of treatment optimization for this category of patients, which consists of structural therapeutic patient education and intensive observation after their discharge from hospital.
References
1. Бенделиани, Н. Г. Качество лечения в амбулаторных условиях больных ишемической болезнью сердца очень высокого риска после кардиохирургического вмешательства / Н. Г. Бенделиани // Бюллетень НЦССХ им. А. Н. Бакулева РАМН. - 2009. - Т. 10, № 4. - С. 45-50.
2. Бокерия Л. А. Потребность в хирургических и эндоваскулярных методах лечения при ишемической болезни сердца / Л. А. Бокерия, И. Н. Ступаков, И. В. Самородская и др. // Мед. вестн. - 2008. - № 34 (461). - С. 3.
3. Anderson, R. T. Issues of Aging and Adherence to Health Interventions / R. T. Anderson, M. Ory, S. Cohen, J. S. McBride // Control. Clin. Trials. - 2000. - Vol. 5. - P. S171-S182 (Suppl. 1).
4. Cacoub, P. P. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registy / P. P. Cacoub, M. T. Abola, I. Baumgartner et al. // Atherosclerosis. - 2009. - Vol. 204, № 2. - P. e86-92.
5. Grundy, S. M. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines / S. M. Grundy, J. A. Cleeman, C. N. B. Merz // Circulation. - 2004. - Vol. 10. - P. 227-239.
6. Michalsen, A. Preventable causative factors leading to hospital admission with decompensated heart failure / A. Michalsen, G. Kunig, W. Thimme // Heart. - 1998. - Vol. 80. - P. 437-441.
7. Ohman, E. M. The Reduction of Atherothrombosis for Continued Health (REACH) Registry: An international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design / E. M. Ohman, D. L. Bhatt, P. G. Steg et al. // Amer. Heart J. - 2006. - Vol. 151, № 4. - P. 786.e1-786.e10.
8. Sabouret, P. REACH: International prospective observational registry in patients at risk of atherothrombotic events results for the French arm at baseline and one year / P. Sabouret, P. Cacoub, J. Dallongeville et al. // Arch. Cardiovasc. Dis. - 2008. - Vol. 101. - P. 81-88.
9. Smith, S. C. Jr AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease 2006 update endorsed by the National Heart, Lung, and Blood Institute / S. C. Smith Jr, J. Allen, S. N. Blair et al // J. Amer. Coll. Cardiol. - 2006. - Vol. 47. - P. 2130-2139.
10. Steg, P. G. One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis / P. G. Steg, D. L. Bhatt, P. W. F. Wilson et al. // JAMA. - 2007. - Vol. 297. - P. 1197-1206.
11. Steinberg, B. A. Comparisons of Guideline-Recommended Therapies in Patients With Documented Coronary Artery Disease Having Precutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Versus Medical Therapy Only (from the REACH International Registry) / B. A. Steinberg, P. G. Steg, D. L. Bhatt et al. // Coronary Artery Disease / Comparisons of Guideline-Recommendated Therapies by Revascularization, 2007. - P. 1212-1215.
